Investors applauded the company's move to diversify its business.
Compare ZOM Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Zomedica Pharmaceuticals Corp.
News & Analysis: Zomedica Pharmaceuticals Corp.
Investors appear to be bullish about the stock after a major investment bank disclosed earlier this week that it had bought shares of Zomedica.
A lack of sales growth and rising expenses could send this struggling stock even lower.
There are a few glaring reasons behind the once high-flying stock's decline.
Some stocks you can buy and forget. With Zomedica and ContextLogic, you'll want to keep a much closer eye on matters.
Both have been huge winners in recent months.
Or will speculation lead to major disappointment?
A new executive will oversee the company's growth initiatives.
Initial sales of a key product may be lower than investors were hoping for.
The stock has been falling sharply in the past month.